Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].

[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Feb 2016

Harada Yuka, Harada Hironori

Abstract excerpt

Chronic myelomonocytic leukemia (CMML) is one of the clonal myeloid neoplasms characterized by persistent monocytosis and dysplasia of myeloid lineage cells. Thus, CMML includes characteristics of both myelodysplastic syndromes and myeloproliferative neoplasms. Clinical features of CMML are quite heterogeneous. There are no disease-specific gene mutations although more than 90% of CMML patients have one or more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ASXL1 gene
Share to Leukemia, Myelomonocytic, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Myeloproliferative Disorders

Share to Pathology, Molecular

Share to Prognosis

Source

Identifiers

PMID: 26935632
DOI: 10.11406/rinketsu.57.147

Genes

ASXL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].PMID 26935632Read ↗

Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Evolving Understanding of Chronic Myelomonocytic Leukemia: Implications for Future Treatment Paradigms.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: molecular pathogenesis and therapeutic innovationsSemantic proximity Read ↗

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological reviewSemantic proximity Read ↗

Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.Semantic proximity Read ↗

Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies.Semantic proximity Read ↗

[Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].Semantic proximity Read ↗

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia.Semantic proximity Read ↗

How I investigate chronic myelomonocytic leukemia.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and managementSemantic proximity Read ↗

Chronic myelomonocytic leukemia: myeloproliferative variant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.